Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05439551 · ClinicalTrials.gov registry record
Evaluating the Analytical Equivalency of Serum and Whole Blood Samples Run on the MeMed Key® Platform (Perseverance Study)
A clinical trial, sponsored by MeMed Diagnostics.
- Completed
- Registry status
- 215
- Enrollment target
NCT05439551 is a clinical trial that has completed, run by MeMed Diagnostics. The registered enrollment target is 215 participants.
The verdict
NCT05439551 has completed, sponsored by MeMed Diagnostics.
- COMPLETED
- Registry status
- 215 participants
- Enrollment target
Study Summary
This is a Prospective, multi-center, sample collection study enrolling pediatric and adult subjects presented to the ED/Urgent care, with symptoms consistent with acute bacterial or viral infection will be recruited according to eligibility criteria. The study is designed to measure the MeMed BV®️ score in whole blood and serum samples and demonstrate the equivalence between the two matrices. Patients will be managed according to the current standard of care per standard institutional procedures.
Interventions
- DIAGNOSTIC_TEST MeMed BV®
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 215 participants |
| Start Date | 2022-02-11 |
| Est. Completion | 2023-09-29 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05439551
The ClinicalTrials.gov registry entry for NCT05439551 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 215 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is MeMed Diagnostics, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which MeMed BV® is the first listed.
NCT05439551 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05439551 about?
NCT05439551 is a clinical study titled "Evaluating the Analytical Equivalency of Serum and Whole Blood Samples Run on the MeMed Key® Platform (Perseverance Study)". This is a Prospective, multi-center, sample collection study enrolling pediatric and adult subjects presented to the ED/Urgent care, with symptoms consistent with acute bacterial or viral infection will be recruited according to eligibility criteria. The study is designed to measure the MeMed BV®️ s...
What is the current status of trial NCT05439551?
This trial is currently completed. The enrollment target is 215 participants. The study started on 2022-02-11. Estimated completion is 2023-09-29.
What interventions are being tested in trial NCT05439551?
The interventions under investigation include: MeMed BV® (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05439551?
This trial is sponsored by MeMed Diagnostics, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.